Print PDF

Practice Areas

FTZ Board Approves Subzone at Connecticut Insulin Facility

Thursday, January 21, 2016
Sandler, Travis & Rosenberg Trade Report

The Foreign-Trade Zones Board has approved the establishment of subzone 76B at the MannKind Corporation facilities in Danbury, Conn., which are used for the production of inhalable insulin. Production under zone procedures at these facilities is currently under review.

To get news like this in your inbox daily, subscribe to the Sandler, Travis & Rosenberg Trade Report.

Customs & International Headlines